Mala Shanmugam, MS, PhD , Emory School of Medicine, Atlanta, GA, comments on altered metabolism in multiple myeloma, highlighting the importance of better understanding the impact of metabolic alterations on therapy sensitivity and resistance. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.